Significant Ownership of Peter Evan Harwin

Location
West Conshohocken, PA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Peter Evan Harwin.

Notify me when Peter Evan Harwin files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Peter Evan Harwin

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
APGE Apogee Therapeutics, Inc. Common Stock, $0.00001 par value 10% $456,430,807 +$20,390,674 6,047,027 +4.7% Peter Evan Harwin 22 Jan 2026
SYRE SPYRE THERAPEUTICS, INC. Common Stock, $0.0001 par value 10% $136,033,480 8,106,882 Peter Evan Harwin 15 Oct 2025

Schedules 13D/G Reported by Peter Evan Harwin:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.